New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its ...
In Q1 FY26, cash receipts from customers were A$15k. The net cash used in G&A activities in the quarter was A$578k, compared to A$1.44 million in Q4 FY25. Payments to Related Parties comprises ...
Novel targeted therapies for ARID1A-mutant and CDA-resistant cancers highlighted MENLO PARK, CA / ACCESS Newswire / October 27, 2025 / Edison Oncology, a clinical-stage biopharmaceutical company ...
Q3 2025 Earnings Call Transcript October 29, 2025 OPKO Health, Inc. beats earnings expectations. Reported EPS is $0.03, ...
UCSF researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco, which ran from Sept. 27 to ...
Dr. Bernd Pichler is a distinguished pioneer in preclinical and translational imaging, renowned for his groundbreaking work in multimodal imaging and imaging tracer development. As chair of the ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Premiere Pro is often used in conjunction with other Creative Cloud apps in the Adobe software list, including After Effects, ...
for Research & Graduate Education Corinne Lengsfeld on Wednesday, Oct. 22 from noon-1 p.m. as she provides updates from the ...
Seagriculture EU 2026, one of Europe’s leading conferences for the seaweed industry, will be held in Gothenburg, Sweden, from ...